Please assess the completion status of the following clinical trial:

Trial Title: An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com~Inclusion Criteria:~* Plaque psoriasis for at least 6 months~* Moderate to severe disease~* Candidate for phototherapy or systemic therapy~Exclusion Criteria:~* Other forms of psoriasis~* History of recent infection~* Prior exposure to BMS-986165 or active comparator~Other protocol defined inclusion/exclusion criteria could apply

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- BMS-986165 (Type: EXPERIMENTAL): BMS-986165 oral administration
- Placebo (Type: PLACEBO_COMPARATOR): Placebo oral administration
- Active comparator (Type: ACTIVE_COMPARATOR): Active comparator oral administration

Based on this trial design, predict the completion outcome and termination type (if applicable).